FRIDAY, DECEMBER 13, 2024
Download The Full Agenda
7:00 am
Registration and Continental Breakfast
Stern Lobby
7:30 am
Welcome and Introduction
Ash Tewari, MBBS, MCh, FRCS (Hon.), Dsc. (Hon.)
SESSION I | KEYNOTE LECTURE
7:40 am
Cutting-Edge Approaches in Kidney Cancer: Advances in Imaging Techniques and Innovative Minimally Invasive Treatments
Ketan Badani, MD, FRCS (Hon.)
7:55 am
BREAK / Intro to Live Case
SESSION II | LIVE CASE #2
SINGLE PORT (SP) LOW ANTERIOR ACCESS RETROPERITONEAL PARTIAL NEPHRECTOMY
8:05 am
Surgeon: Ketan Badani, MD, FRCS (Hon.)
Moderator: Alexandre Mottrie (Prof.), MD, PhD
Panel: Simone Crivellaro, MD, MHA; Brian Shuch, MD; Craig Rogers, MD
9:15 am
BREAK / VISIT EXHIBITS
FRIDAY, DECEMBER 13
SESSION III | THE OPENING ACT
FROM SCREENING TO DIAGNOSIS TO SURVEILLANCE
Moderator: Laurence Klotz, CM, MD
Panelists: Ash Tewari, MBBS, MCh; Peter Pinto, MD; Ming Zhou, MD, PhD; Samir S. Taneja, MD
9:30 am
Business, Economics, and Regulations in Urology
Deepak A. Kapoor, MD
9:45 am
Lancet Commission on Prostate Cancer
Nick James (Prof) MBBS, PhD
10:00 am
Online Misinformation About Prostate Cancer
Stacy Loeb, MD, MSc, PhD (Hon.)
10:15 am
Should We Keep Calling ISUP 1 Prostate Cancer?
Ming Zhou, MD, PhD
10:30 am
State-of-the-Art Lecture on Multicancer Early Detection
Eric Klein, MD
10:45 am
How to Use Polygenic Risk Ratios in Stratifying Patients for Prostate Cancer
Sujit Nair, PhD
11:00 am
Q&A
SESSION III | THE OPENING ACT, Continued
FROM SCREENING TO DIAGNOSIS TO SURVEILLANCE
Moderator: Eric Klein, MD
Panelists: Neal Shore, MD, FACS; Mani Menon, MD; Laurence Klotz, CM, MD; Mitchell Benson, MD
11:15 am
TP Biopsy- The New Standard of Care
Jim Hu, MD, MPH
11:30 am
Use of Testosterone Replacement Therapy in Patients on Active Surveillance and Post PCa Treatment
Leon Telis, MD
11:45 am
Active Surveillance: When to Intervene and the Role of Imaging and Genomics
Peter Pinto, MD
12:00 pm
Genomics and Clinical Significance of MR Visible vs Invisible Cancers
Laurence Klotz, CM, MD
12:30 pm
Use of PSMA in Active Surveillance Risk Stratification - HOLOGRAM
Declan Murphy, MB, BCH, FRACS, FRCS (Urol)
12:30 pm
Lunch / Visit Exhibits
SESSION V
EMERGING FRONTIERS IN METASTATIC AND ADVANCED PROSTATE CANCER
Moderator: Natasha Kyprianou, MBBS, PhD
Panel: Himisha Beltran, MD, FRCS; Richard Stock, MD; Sujit S. Nair, PhD; Mitchell Benson, MD
1:20 pm
Update on Prostatic Intra-Acinar Neoplasia: Precursors and Beyond
Angelo M. De Marzo, MD, PhD
1:35 pm
Emerging Mechanisms of Treatment Resistance in Advance Prostate Cancer
Himisha Beltran, MD, FRCS
1:50 pm
Biology of Prostate Cancer Metastases: Implications for Treatment
Simpa Salami, MD, MPH
2:05 pm
Neoadjuvant Apalutamide and Downstaging Prostate Cancer
Isaac Yi Kim (Prof.), MD, PhD, MBA
2:20 pm
Surgeon Scientist Journey in Advanced Prostate Cancer
Martin Gleave, MD
2:35 pm
Q&A
Moderator: Isaac Yi Kim (Prof.), MD, PhD, MBA
Panel: Himisha Beltran, MD; Richard Stock, MD; Sujit S. Nair, PhD
2:45 pm
National Prostate Cancer Screening in Sweden
Anna Lantz, MD, PhD
3:00 pm
German Prostate Cancer Screening Trial PROBASE
Peter Albers, MD
3:15 pm
Oncological Outcomes after Lymph Node Dissection vs No LND for High Risk Prostate Cancer
Peter Wiklund, MD, PhD
3:30 pm
Intensification versus De-Intensification Strategies in Prostate Cancer
Neal Shore, MD, FACS
3:45 pm
Prostate Cancer: Navigating the Landscape from HS to CRPC
Cora Sternberg (Prof.), MD, FACP
SESSION V | Kidney
Moderator: Aditya Bagrodia, MD
Panel: Alessandro Volpe (Prof.), MD; Todd Morgan, MD; Michael Palese, MD
4:00 pm
KEYNOTE LECTURE
Ketan Badani, MD, FRCS (Hon.)
4:15 pm
The Evolving Management of Small Renal Masses: Advances in Active Surveillance and Future Perspectives
Craig Rogers, MD
4:30 pm
Overview of Genomic Biomarkers in Clear Cell Renal Cell Carcinoma
Brian Shuch, MD
4:45 pm
Modern Approach to Robotic Partial Nephrectomy for Hilar Tumors
Jihad Kaouk, MD
5:00 pm
Q&A
5:15 pm
Closing Remarks
Ketan Badani, MD, FRCS
This website uses cookies.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.